{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T10:30:39Z","timestamp":1770373839373,"version":"3.49.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Mycobacterium kansasii usually causes chronic pulmonary infections in immunocompetent patients. In contrast, disseminated M. kansasii disease is commonly associated with advanced human immunodeficiency virus infection, but is reported infrequently in other immunocompromised patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify common clinical manifestations and potential risk factors for M. kansasii infection in patients with GATA2 deficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We reviewed M. kansasii disease associated with GATA2 deficiency at one institution and disease associated with primary and other immunodeficiencies reported in the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Nine patients with GATA2 deficiency developed M. kansasii infections. Six patients developed disseminated disease. All patients presented with significant mediastinal lymphadenopathy or abscesses. Seven patients had pulmonary risk factors, including six smokers. The majority of patients had low numbers of neutrophils, monocytes, B cells, CD4+ T cells, and natural killer cells. Other conditions associated with disseminated M. kansasii disease were thymic disorders and IFN-\u03b3\/IL-12 defects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Disseminated M. kansasii disease involving mediastinal lymph nodes is surprisingly common in GATA2 deficiency, but also occurs in defects of IFN-\u03b3 synthesis and response. Disseminated M. kansasii should be considered a marker indicating a need to evaluate for immunodeficiency syndromes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201603-207bc","type":"journal-article","created":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T15:28:31Z","timestamp":1473348511000},"page":"2169-2173","source":"Crossref","is-referenced-by-count":10,"title":["Mediastinal and Disseminated\n                    <i>Mycobacterium kansasii<\/i>\n                    Disease in GATA2 Deficiency"],"prefix":"10.1093","volume":"13","author":[{"given":"Jana P.","family":"Lovell","sequence":"first","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa S.","family":"Zerbe","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth N.","family":"Olivier","sequence":"additional","affiliation":[{"name":"Pulmonary Clinical Medicine Section, Cardiovascular and Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reginald J.","family":"Claypool","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathleen","family":"Frein","sequence":"additional","affiliation":[{"name":"Clinical Research Directorate, Clinical Monitoring Research Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria L.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"2026020502562621300_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502562621300_bib2","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1086\/513666","article-title":"Mycobacterium kansasii disease in patients infected with human immunodeficiency virus","volume":"24","author":"Campo","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2026020502562621300_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.humpath.2014.11.005","article-title":"Fatal aortic pseudoaneurysm from disseminated Mycobacterium kansasii infection: case report","volume":"46","author":"Ehsani","year":"2015","journal-title":"Hum Pathol"},{"key":"2026020502562621300_bib4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/ppul.20659","article-title":"Broncholithiasis in an immune compromised boy with disseminated Mycobacterium kansasii","volume":"42","author":"Cuppen","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"2026020502562621300_bib5","first-page":"S84","article-title":"Clinical features and immunological abnormalities of GATA2 deficiency in Japan","volume":"32","author":"Honma","year":"2012","journal-title":"J Clin Immunol"},{"key":"2026020502562621300_bib6","first-page":"350","article-title":"Granulomatous lung disease in a patient with a family history of hematological disorders","volume":"31","author":"Overbeek","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026020502562621300_bib7","first-page":"S239","article-title":"A case of dendritic cell, monocyte, B and NK lymphoid deficiency (DCML)","volume":"34","author":"Dullaers","year":"2014","journal-title":"J Clin Immunol"},{"key":"2026020502562621300_bib8","first-page":"150","article-title":"The manifold faces of GATA 2 deficiency: a case report","volume":"35","author":"Wehr","year":"2012","journal-title":"Onkologie"},{"key":"2026020502562621300_bib9","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"2026020502562621300_bib10","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"key":"2026020502562621300_bib11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"2026020502562621300_bib12","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/IAI.71.9.4943-4952.2003","article-title":"Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii\u2013infected hosts","volume":"71","author":"Lasbury","year":"2003","journal-title":"Infect Immun"},{"key":"2026020502562621300_bib13","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1542\/peds.109.6.e97","article-title":"Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother","volume":"109","author":"Dupuis-Girod","year":"2002","journal-title":"Pediatrics"},{"key":"2026020502562621300_bib14","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1086\/605532","article-title":"Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-\u03b3 receptor 1 deficiency","volume":"49","author":"Vinh","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2026020502562621300_bib15","author":"Buckland"},{"key":"2026020502562621300_bib16","first-page":"10","article-title":"A non-HIV case with disseminated Mycobacterium kansasii disease associated with strong neutralizing autoantibody to interferon-\u03b3","volume":"8","author":"Nei","year":"2012","journal-title":"Respir Med Case Rep"},{"key":"2026020502562621300_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10875-015-0171-3","article-title":"Disseminated Mycobacterium kansasii disease in complete DiGeorge syndrome","volume":"35","author":"Yin","year":"2015","journal-title":"J Clin Immunol"},{"key":"2026020502562621300_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archpedi.1970.02100070087011","article-title":"Primary lymphopenic immunologic deficiency: disseminated Mycobacterium kansasii infection","volume":"120","author":"McCracken","year":"1970","journal-title":"Am J Dis Child"},{"key":"2026020502562621300_bib19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0022-3476(74)80009-0","article-title":"The lack of effect of transfer factor in thymic dysplasia with immunoglobulin synthesis","volume":"84","author":"Pachman","year":"1974","journal-title":"J Pediatr"},{"key":"2026020502562621300_bib20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0022-3476(70)80291-8","article-title":"Thymic alymphoplasia, previously reported as dysgammaglobulinemia type I","volume":"76","author":"Cashman","year":"1970","journal-title":"J Pediatr"},{"key":"2026020502562621300_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0090-1229(81)90165-3","article-title":"Disseminated Mycobacterium kansasii infection","volume":"20","author":"McGeady","year":"1981","journal-title":"Clin Immunol Immunopathol"},{"key":"2026020502562621300_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1468-1293.2004.00249.x","article-title":"Epidemiological, clinical and therapeutic features of AIDS-related Mycobacterium kansasii infection during the HIV pandemic: an 11-year follow-up study","volume":"5","author":"Manfredi","year":"2004","journal-title":"HIV Med"},{"key":"2026020502562621300_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1164\/ajrccm\/139.1.4","article-title":"The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS)","volume":"139","author":"Horsburgh","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"2026020502562621300_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0163-4453(98)92014-X","article-title":"Mycobacterium kansasii and human immunodeficiency virus co-infection in London","volume":"37","author":"Klein","year":"1998","journal-title":"J Infect"},{"key":"2026020502562621300_bib25","first-page":"673","article-title":"Mycobacterium kansasii disease among patients infected with human immunodeficiency virus type 1: improved prognosis in the era of highly active antiretroviral therapy","volume":"7","author":"Santin","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026020502562621300_bib26","first-page":"331","article-title":"Mycobacterium kansasii in HIV patients: clarithromycin and antiretroviral effects","volume":"11","author":"Tompkins","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026020502562621300_bib27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3346\/jkms.2010.25.2.304","article-title":"Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature","volume":"25","author":"Han","year":"2010","journal-title":"J Korean Med Sci"},{"key":"2026020502562621300_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/1097-0142(19810715)48:2<380::AID-CNCR2820480226>3.0.CO;2-N","article-title":"Hairy cell leukemia: association with disseminated atypical mycobacterial infection","volume":"48","author":"Weinstein","year":"1981","journal-title":"Cancer"},{"key":"2026020502562621300_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ajh.2830160410","article-title":"Infectious complications in 127 patients with hairy cell leukemia","volume":"16","author":"Golomb","year":"1984","journal-title":"Am J Hematol"},{"key":"2026020502562621300_bib30","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0002-9343(86)90634-0","article-title":"Disseminated atypical mycobacterial infection in patients with hairy cell leukemia","volume":"80","author":"Bennett","year":"1986","journal-title":"Am J Med"},{"key":"2026020502562621300_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ajh.10410","article-title":"Disseminated Mycobacterium kansasii infection with pulmonary alveolar proteinosis in a patient with chronic myelogenous leukemia","volume":"74","author":"Goldschmidt","year":"2003","journal-title":"Am J Hematol"},{"key":"2026020502562621300_bib32","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/clinids\/12.5.760","article-title":"Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience","volume":"12","author":"Lillo","year":"1990","journal-title":"Rev Infect Dis"},{"key":"2026020502562621300_bib33","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1086\/313967","article-title":"Mycobacterium kansasii infections in patients with cancer","volume":"31","author":"Jacobson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2026020502562621300_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/pgmj.2004.026229","article-title":"Clinical features and follow up of 302 patients with Mycobacterium kansasii pulmonary infection: a 50 year experience","volume":"81","author":"Maliwan","year":"2005","journal-title":"Postgrad Med J"},{"key":"2026020502562621300_bib35","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/infdis\/jit400","article-title":"Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease","volume":"208","author":"Berenson","year":"2013","journal-title":"J Infect Dis"},{"key":"2026020502562621300_bib36","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.201407-1385OC","article-title":"Cigarette smoking impairs human pulmonary immunity to Mycobacterium tuberculosis","volume":"190","author":"O\u2019Leary","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502562621300_bib37","first-page":"1108","article-title":"Current cigarette smoking among adults\u2014United States, 2005\u20132013","volume":"63","author":"Jamal","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/12\/2169\/66768607\/annalsats_13_12_2169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/12\/2169\/66768607\/annalsats_13_12_2169.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:56:36Z","timestamp":1770278196000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/13\/12\/2169\/8449364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,1]]},"published-print":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201603-207bc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,12]]},"published":{"date-parts":[[2016,12,1]]}}}